Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

NCT03072238 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1101

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Prostate Cancer

Interventions

DRUG: Ipatasertib
DRUG: Abiraterone
DRUG: Placebo
DRUG: Prednisone/Prednisolone

Sponsor

Hoffmann-La Roche